Corbus Pharmaceuticals Holdings, Inc. (CRBP) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$1,212
Total Return
-87.88%
CAGR
-34.44%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +3.96% |
| Median | -5.74% |
| Best | +446.11% |
| Worst | -69.28% |
| % of Windows Positive | 40.3% |
1-Year (252 Trading Days)
| Average | +87.42% |
| Median | -11.98% |
| Best | +1992.44% |
| Worst | -89.53% |
| % of Windows Positive | 46.4% |
3-Year (756 Trading Days)
| Average | +39.44% |
| Median | +8.77% |
| Best | +485.45% |
| Worst | -69.63% |
| % of Windows Positive | 54.0% |
Risk Metrics
| Maximum Drawdown | -96.77% |
| Average Drawdown | -74.73% |
| Drawdown Duration | 1251 Trading Days (Unrecovered) |
| Sortino Ratio | 0.63 |
| Calmar Ratio | -0.36 |
| CVaR (5%) | -13.62% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -9.34% (-20.74% ann.) | $933.62 | $0.00 | $0.00 | $0.00 |
| 2025 | -31.02% | $3101.72 | $0.00 | $0.00 | $0.00 |
| 2024 | +95.36% | +$9536.44 | $0.00 | $0.00 | $0.00 |
| 2023 | +81.38% | +$8138.11 | $0.00 | $0.00 | $0.00 |
| 2022 | -81.98% | $8198.05 | $0.00 | $0.00 | $0.00 |
| 2021 | -50.72% | $5072.01 | $0.00 | $0.00 | $0.00 |
| 2020 | -77.11% | $7710.62 | $0.00 | $0.00 | $0.00 |
| 2019 | -6.51% | $650.69 | $0.00 | $0.00 | $0.00 |
| 2018 | -17.75% | $1774.65 | $0.00 | $0.00 | $0.00 |
| 2017 | -15.98% | $1597.63 | $0.00 | $0.00 | $0.00 |
| 2016 | +412.12% | +$41212.13 | $0.00 | $0.00 | $0.00 |
| 2015 | -44.82% | $4481.61 | $0.00 | $0.00 | $0.00 |
| 2014 partial | -0.33% (-1.86% ann.) | $33.33 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | October 27, 2014 – February 19, 2020 | +90.00% | +12.84% | +$9000.00 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -15.17% | -84.70% | $1516.76 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | -76.21% | -90.08% | $7621.05 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -30.16% | -28.87% | $3016.40 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -85.53% | -87.16% | $8553.23 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +1215.25% | +301.53% | +$121524.65 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | -85.04% | -67.17% | $8503.95 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.